APA (7th ed.) Citation

YH, J., N, L., J, Y., S, W., SK, S., KH, K., . . . DS, L. (2022). Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy. Biomedicines, 10(4), . https://doi.org/10.3390/biomedicines10040805

Chicago Style (17th ed.) Citation

YH, Jeon, et al. "Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy." Biomedicines 10, no. 4 (2022). https://doi.org/10.3390/biomedicines10040805.

MLA (9th ed.) Citation

YH, Jeon, et al. "Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8+ T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy." Biomedicines, vol. 10, no. 4, 2022, https://doi.org/10.3390/biomedicines10040805.